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Mutations in GJB2 gene are the leading cause of deafness in autosomal recessive inheritance, and 
the 35delG mutation is the most common in many ethnic groups. Besides the 35delG mutation in 
homozygosis, the mutation is also found in compound heterozygosis, coupled with other mutations 
in genes GJB2 and GJB6. 
Aim: To determine the prevalence of 35delG/GJB2 and del (GJB6-D13S1830) mutations in patients 
with sensorineural hearing impairment in residents from the Espirito Santo state, Brazil. 
Materials and methods: 77 unrelated individuals with moderate to profound sensorineural hearing 
loss were evaluated. The 35delG mutation was studied by PCR / RFLP; and the del (GJB6-D13S1830) 
mutation was screened by the technique of multiplex PCR. 
Results: 88.3% had normal genotype for the studied mutations, 1.3% were compound heterozygotes, 
3.9% homozygotic for the 35delG mutation, 6.5% heterozygotic for 35delG/GJB2. The frequency 
of 35delG/GJB2 and del (D13S1830/GJB6) alleles in the sample was 7.8% and 0.65%, respectively. 
Conclusion: The data confirmed the existence of the mutations studied in cases of sensorineural 
hearing loss in a population from Espírito Santo / Brazil. These findings reinforce the importance 
of genetic diagnosis, which can provide early treatment for children and genetic counseling for the 
affected families.
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INTRODUCTION
Deafness is the most frequent sensory deficit in 
human beings; its reported incidence worldwide ranges 
from 1:300 to 1:1,000 children.1-3 The frequency in Brazil 
is estimated at 4:1,000 births.4 The etiology is genetic in 
about half of the cases worldwide; this includes syndro-
mic and non-syndromic forms. Non-syndromic deafness 
accounts for 60 to 70% of inherited deafness that involve 
over 100 different genes, as follows: autosomal dominant 
(DFNA), autosomal recessive (DFNB), X-linked (DFN), 
and mitochondrial inheritance,5 of which the autosomal 
recessive inherited pattern is the most common. In several 
populations, the most frequent cause of non-syndromic 
autosomal recessive deafness occurs because of an altered 
connexin 26 protein, a communicating gap junction protein 
encoded by the gene GJB2 (13q11-12) (OMIM 121011).6-13
Connexins are transmembrane proteins that form 
cell surface cylindrical hexameric structures which bind 
to other connexin hexamers in adjacent cells to form 
intercellular communication channels.14,15 Connexin 26 
may be associated with other connexins in the inner ear. 
Connexin 26 recycles potassium ions as part of a signal 
transduction mechanism in the inner ear.16
Mutations in three connexin encoding genes, GJB2 
(Cx 26), GJB6 (Cx 30), and GJB3 (Cx 31) have been found 
to cause hearing loss.15,16
The 35delG mutation accounts for most of the 
mutant alleles (60-85%) in Caucasians, among the DFNB-
causing GJB2 gene mutations described so far.6,7,9-13,17
The 35delG mutation is a deletion of a guanine 
base in a sequence of six guanines that extend from nu-
cleotide positions 30 to 35 on the GJB2 gene encoding 
exon, resulting in a stop codon. This deletion causes the 
polypeptide to be synthesized incompletely; it contains 
12 amino acids, rather than the usual 226 amino acids.18
Analyses of the GJB2 gene in patients with auto-
somal recessive inherited deafness, especially because of 
the 35delG mutation, have shown that about 10 to 50% 
presented only one mutant allele.19 Other studies have 
suggested that there may be another mutation on the enco-
ding exon of the Cx 26 gene; or the del (GJB6-D13S1830) 
mutation may coexist with the Cx 30 gene in heterozygote 
individuals for the GJB2 gene.20-22
Environmental factors cause about 80% of hearing 
loss cases in Brazil; the remaining 20% supposedly are of 
inherited causes.4 A recent study in the state of Sao Paulo 
has shown that the 35delG mutation was the most frequent 
in their sample (12.4%); it was found in 23% of the family 
cases, and 6.2% of the sporadic cases. The second most 
frequent mutation that these authors found was the del 
(GJB6-D13S1830) deletion on the GJB6 gene, which was 
found in 1% of cases and always coexisted with the 35delG 
mutation on the GJB2 gene.23
Estimates of the prevalence of 35delG heterozygotes 
in several European countries range from 2 to 4% of the 
normal hearing population.6,17 A Brazilian study revealed 
that 1 in 51 Caucasians (1.9%) have the 35delG mutation, 
which is similar to most European populations.24 Ano-
ther study of neonates in Sao Paulo state showed that 
the 35delG mutation was present in 1 of 103 neonates 
(0.97%).25
Finding the prevalence of mutations in Brazil may 
help implement expedited molecular diagnosis tests to 
inform physicians about therapy, along with genetic 
counseling for family members of patients. It is therefore 
essential to learn about the genetic diversity of deafness 
to design improved proposals for the molecular diagnosis 
of population groups.26
The purpose of this study was to estimate the preva-
lence of the 35delG and D13S1830 mutations of the GJB2 
and GJB6 genes in a sample of patients from Espirito Santo 
(Southeast Brazil), with bilateral prelingual non-syndromic 
sensorineural hearing loss of unknown causes.
MATERIALS AND METHODS
Patients and samples
A cross-sectional cohort study included 77 unrelated 
hearing loss patients, of which 38 were male and 39 were 
female. The age of patients ranged from 1 to 52 years. All 
resided in the state of Espirito Santo.
Patients came from auditory oral schools and hea-
ring loss patient support centers in several regions of Espi-
rito Santo; a clinical history to identify the onset of hearing 
loss, the presence of other cases in their families, to confirm 
non-syndromic deafness, and to exclude ambient causes, 
such as prenatal infection (rubella, toxoplasmosis, herpes, 
and post-natal infection, especially bacterial meningitis and 
exposure to ototoxic drug use. An audiological evaluation, 
immittance testing, audiological post-evaluation, pure tone 
audiometry and/or behavioral audiometry, and otoacoustic 
emissions testing showed that all patients had bilateral 
moderate to profound sensorial hearing loss.
Patients or caretakers signed a free informed con-
sent form and provided 03 ml of peripheral blood for 
laboratory testing. The institutional review board of the 
Integrated Healthcare Center (Centro Integrado de Aten-
ção à Saude or CIAS) approved this study (protocol no. 
121/2006). A commercial DNA-extraction kit (Puregene 
DNA Purification Kit - Gentra Systems) was used to extract 
genomic DNA according to the manufacturer’s instructions.
Screening for mutations
A primer pair (F: 5 TCT TTT CCA GAG CAA ACC 
GC 3 and R: 5 GCT GGT GGA GTG TTT GTT CAC ACC 
CGC 3 ) was used to amplify the genomic region at 65°C 
annealing temperature for analyzing the 35delG mutation 
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on the GJB2 gene. The resulting 89 bp PCR product was 
digested with the BstNI restriction enzyme. In the absence 
of deletions, the enzyme yields two fragments (69 bp and 
20 bp); if the deletion is present, the enzyme does not cut 
the DNA (89 bp). The digested fragments were analyzed 
in 8% polyacrylamide gel electrophoresis.27
The del (GJB6-D13S1830) mutation was tracked 
using the PCR multiplex technique with three primers 
(F: 5 TTT AGG GCA TGA TTG GGG TGA TTT - 3; R1: 5 
CAC CAT GCG TAG CCT TAA CCA TTTT - 3; R2: 5’ TCA 
TCG GGG GTG TCA ACA AACA - 3’) at 62°C annealing 
temperature.20,21 The F and R1 primers were used to detect 
the deletion, and the primer R2 was used to find the nor-
mal allele which amplifies a fragment within the deleted 
region. Two PCR products are obtained when the three 
primers are applied together, which makes it possible to 
separate homozygote, heterozygote or normal homozygote 
individuals. The amplified product was analyzed in 1.5% 
agarose gel electrophoresis.
RESULTS
We originally evaluated 308 subjects with hearing 
loss; 77 of these had no environmental causes for their 
clinical picture, and were included in the study (25% of 
cases).
The 77 subjects with idiopathic deafness underwent 
molecular screening for the 35delG mutation in the GJB2 
gene and the del (D13S1830) mutation in the GJB6 gene. 
The 35delG mutation was found in homozygosis in three 
patients (3.9% of cases), which established the etiology in 
these subjects. The 35delG mutation was found in hetero-
zygosis in five subjects (6.5% of cases), but the presence 
of a single allele did not explain the cause of deafness 
in these patients. Normal and heterozygotic patients for 
the 35delG mutation were also investigated for the del 
(GJB6-D13S1830) mutation; one among 74 subjects had this 
mutation (1.35% dos cases). The heterozygotic patient for 
the del (D13S1830/GJB6) mutation was also heterozygotic 
for the 35delG/GJB2 mutation, which defined the double 
genetic etiology for this patient. These mutations were not 
found in 68 patients; other related mutations to Cx26 and 
Cx30 may be associated with the clinical pictures of these 
patients. Table 1 presents the results.
The frequency of the 35delG/GJB2 mutant allele in 
the sample was 7.8%; the frequency of the del (D13S1830/
GJB6) mutant allele was 0.65%.
DISCUSSION
The genetic heterogeneity of non-syndromic hearing 
loss makes its molecular diagnosis more complicated, gi-
ven the number of mutations that have been described in 
dearness-related genes; additionally, the predominance of 
each varies significantly in different populations.
The 35delG mutation in the GJB2 gene is the main 
cause of genetic deafness in Caucasian populations; it 
may be found in homozygosis or compound heterozygo-
sis (with other mutations in the GJB2 and GBJ6 genes).4,7 
The del (GJB6/D13S1830) mutation is the second most 
frequent DFNB-related mutation in European, Jewish and 
Brazilian populations.7,23
The frequency of the 35delG/GJB2 mutant alleles 
may vary in different regions of the world, as follows: 
United States of America (1.0%); Australia (1.0%); Austria 
(1.7%); Turkey (1.8%); Portugal (2.2%); Spain (2.5%), 
France (2.7%), and Italy (2-4%).28,13,29,30,17,31
Because of widespread racial mixing in Brazil, the 
35delG/GJB2 mutation is not rare. Three studies in the 
state of Sao Paulo have revealed mutant allele frequencies 
ranging from 0.97% to 2.24%.22,25,32
A survey in 10 cities in different regions of Brazil 
revealed the following frequencies for 35delG mutation: 
North region (2.1%); Southeast region (1.5%); South region 
(1.2%), and Northeast region (0.8%); these differences 
were not significant.33
In the present study, the 35delG/GJB2 mutation and 
the del (D13S1830/GJB6) mutation were investigated in pa-
tients with idiopathic deafness in the state of Espirito Santo, 
Brazil. Among 77 subjects, nine unrelated individuals had 
the 35delG/GJB2 mutation; of these, one had the mutation 
in compound heterozygosis with the D13S1830 mutation in 
the GJB6 gene. The frequencies of the 35delG/GJB2 and 
del (GJB6-D13S1830) mutant alleles in the sample were 
respectively 7.8% and 0.65%. Our data concur with other 
studies done in the Brazilian population (Tables 2 and 3) 
and with several other studies that have documented the 
incidence of GJB2 and GJB6 gene mutations in patients 
with non-syndromic prelingual deafness.28,29,34-40
Although molecular analysis of hearing loss is not 
frequent in developing countries, it is essential to investi-
gate GJB2 and GJB6 gene mutations for public health and 
genetic counseling purposes. The proportion of hearing 
loss patients because of genetic causes tends to increase 
as a result of investments and improvements in healthcare 
systems in developing countries such as Brazil. Establishing 
the prevalence and the types of mutations that cause 
non-syndromic hearing loss in Brazil, as was done in this 
study, may help implement simple and specific models 
Table 1. Results of genetic investigation in this study
Genotypes No. of subjects/ total sample
35delG/35delG 3/77 (3.9%)
35delG/ N 5/77 (6.5%)
35delG/del (GJB6-D13S1830) 1/77 (1.3%)
N/N 68/77 (88.3%)
N: Absence of the 35delG/GJB2 and del (GJB6-D13S1830) mutations.
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to detect the main mutations causing genetic deafness in 
this country. The molecular diagnosis leads to accurate 
genetic counseling for family members and makes it 
possible to provide early rehabilitation for the children in 
affected families.
CONCLUSION
Our data confirmed the presence of the 35delG 
mutation in the GJB2 gene in cases of non-syndromic 
bilateral moderate to profound sensorineural hearing loss 
in Espirito Santo, Brazil, a result which concurs with other 
published findings. The del (GJB6-D13S1830) mutation 
was found in compound heterozygosis with the 35delG/
GJB2 mutation in one patient. These findings underline 
the importance of a genetic diagnosis that may clarify 
the etiology and provide early treatment for children and 
genetic counseling for their family members.
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